SPINOCEREBELLAR ATAXIA TYPE 10

Clinical trials for SPINOCEREBELLAR ATAXIA TYPE 10 explained in plain language.

Never miss a new study

Get alerted when new SPINOCEREBELLAR ATAXIA TYPE 10 trials appear

Sign up with your email to follow new studies for SPINOCEREBELLAR ATAXIA TYPE 10, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New drug trial aims to slow progression of rare movement disorder

Disease control Ongoing

This study is testing whether a daily medication called troriluzole can help slow the worsening of movement, balance, and speech problems in adults with inherited spinocerebellar ataxia (SCA). About 300 participants with specific types of SCA will take either troriluzole or a pla…

Matched conditions: SPINOCEREBELLAR ATAXIA TYPE 10

Phase: PHASE3 • Sponsor: Biohaven Pharmaceuticals, Inc. • Aim: Disease control

Last updated Apr 02, 2026 06:56 UTC

SPINOCEREBELLAR ATAXIA TYPE 10

Get alerted when new SPINOCEREBELLAR ATAXIA TYPE 10 trials appear

New drug trial aims to slow progression of rare movement disorder